Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 5

First Capital, Inc. Announces Quarterly Dividend

CORYDON, Ind., May 22, 2013 (GLOBE NEWSWIRE) -- The Board of Directors of First Capital, Inc. (Nasdaq:FCAP) has declared a quarterly cash dividend of $0.20 (twenty cents) per share of common stock, according to William W. Harrod, President and Chief Executive Officer. The dividend will be paid on June 28, 2013 to shareholders of record as of June 14, 2013.  First Capital, Inc. is the holding c...

ACRO Joins CSBI

Aims to attract capital for research-intensive companies

Griffin Capital Essential Asset REIT Reports First Quarter 2013 Results

EL SEGUNDO, Calif., May 22, 2013 (GLOBE NEWSWIRE) -- Griffin Capital Essential Asset REIT, Inc. (the "Essential Asset REIT") announced today its operating results for the first quarter ended March 31, 2013. "The first quarter of 2013 picked up solidly on the strong momentum we were enjoying at the end of last year… and the momentum continues through the second quarter. We started 2013 with th...

North American Partners in Anesthesia Announces Expansion With Addition of New Jersey Anesthesia Group to Its Ranks

MELVILLE, NY--(Marketwired - May 22, 2013) - North American Partners in Anesthesia (NAPA), the largest single specialty anesthesia and perioperative management company in the United States, today announced New Jersey Anesthesia Group (NJAG), located in Paterson, NJ, has joined NAPA. With the addition of NJAG, NAPA continues its expansion in the New Jersey anesthesia market. An additional 73 NJAG...

Islamic Development Bank Triples Authorised Capital to US $150 Billion

DUSHANBE, Tajikistan, May 22, 2013 (GLOBE NEWSWIRE) -- The Islamic Development Bank's Board of Governors (BoG) today approved to more than triple the Bank's authorized capital to 100 billion Islamic Dinars (about US$150 billion) from 30 billion, reflecting the Bank's strong balance sheet and the growing economic development needs of its 56 member countries. The BoG also increased the Bank's subsc...

WeedMaps CEO Comments on Anticipated Election Results for Marijuana Initiatives in Los Angeles

Justin Hartfield, CEO of WeedMaps, the leading online community for the medical marijuana industry and a Ghost Group company, today said no matter what the final results for Tuesday’s election in Los Angeles, the city is making steady progress toward the full legalization of cannabis. “The mere fact that marijuana initiatives are on the ballot speaks...

Climate scientists and finance experts to study the value of climate information

(American Meteorological Society) The American Meteorological Society will assemble leading members of the climate science and finance communities June 3-4, 2013 in Washington, DC to explore climate information needs for financial decision-making. Wo...

CORRECTING and REPLACING GRAPHIC New Index of 5,000 U.S. Physicians Reveals Downward Trend In Profitability For The Year Ahead, With Healthcare Reform Fueling Top Operational Challenges

48% Of Physicians Do Not Foresee Ability to Accept New Patients From Accountable Care Act, Impacting Access To Care, According to Physician Profitability Index Please replace the first graphic with the accompanying graphic. The release reads: NEW INDEX OF 5,000 U.S. PHYSICIANS REVEALS DOWNWARD TREND IN PROFITABILITY FOR THE YEA...

[Kite Pharma] completes $35mm Series A round

[Kite Pharma Inc.] (targeted immunotherapeutics for cancer) raised $35mm through its Series A round. New investor Alta Partners participated, along with all returning major backers including company executive chairman Arie Belldegrun, MD, Pontifax, C...

[Interleukin Genetics] nets $11.2mm via PIPE

Personalized health company [Interleukin Genetics Inc.] netted $11.2mm through the sale of 43.7mm common shares at $0.27 (a 34% discount) to Bay City Capital (20.6mm), Growth Equity Opportunities Fund (15.4mm), Merlin Nexus (5.1mm), Condor Trading (3...

Audax Group Announces Acquisition of Chesapeake IRB

Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc., d/b/a Chesapeake IRB (“Chesapeake”). Headquartered in Columbia, Maryland, Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic m...

Karyopharm Scores $48M Series B To Advance Early Cancer Compounds

The Massachusetts biotech has remained well-funded despite shying away from venture capital investors and seeking funds from private investors.

Novation 2013 Diagnostic Imaging Watch Highlights Latest Product and Practice Trends

IRVING, Texas, May 20, 2013 /PRNewswire/ -- Novation, the leading hospital and health care supply chain expertise, analytics and contracting company for the members of VHA Inc., UHC, Children's Hospital Association, and Provista LLC, released its 2013 Diagnostic Imaging Watch. The report, peer-reviewed by the medical doctors, clinicians and engineers who are members of Novation's Diagnostic I...

Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year

CINCINNATI, May 21, 2013 /PRNewswire/ -- Tom Daulton, CEO of Mammotome, a division of Devicor Medical Products, has been named Dealmaker of the Year by the Cincinnati chapter of the Association for Corporate Growth (ACG). Daulton, who was nominated by another local top executive who is also a breast cancer survivor, led the purchase of the Mammotome® brand from Ethicon Endo-Surgery in Ma...

SAC's Martoma says U.S. impedes defense in fraud case

May 21 (Reuters) - Former SAC Capital Advisors portfolio manager Mathew Martoma said the government is impeding his ability to defend against criminal insider trading charges by trying to link him to an alleged long-running conspiracy for which it ha...

RenovoRx Named Winner of 2013 TiE50 "Top Startup"

SAN JOSE, Calif., May 21, 2013 /PRNewswire/ -- RenovoRx (www.renovorx.com) has been named Winner of the prestigious 2013 TiE50 "Top Startup" Award at TiEcon 2013, the world's largest annual convention for entrepreneurs, for its innovation, strong management team and quality of entrepreneurial ideas. RenovoRx was honored on Saturday, May 18th at the Santa Clara Convention Center. The TiE50 Awards...

BIO Joins Coalition of Small Business Innovators

CSBI Encourages a Tax Code that Promotes Economic Growth and Creates Jobs The Biotechnology Industry Organization (BIO) announced today it has joined the Coalition of Small Business Innovators (CSBI). CSBI is a national, non-partisan coalition of organizations dedicated to stimulating sustained, private investment in small, highly innovative com...

Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives

The Start-up Company Will Develop Therapeutic Antibodies against Novel Targets in the Fields of Cancer and Inflammation Regulatory News: Transgene SA (Euronext Paris: TNG)(Paris:TNG), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, today...

First Aid Shot Therapy®, Inc. ("F.A.S.T.") Completes Series A Financing Round

BURLINGAME, Calif., May 21, 2013 /PRNewswire/ -- First Aid Shot Therapy®, Inc. ("F.A.S.T."), a consumer healthcare company focused on over-the-counter (OTC) therapies in liquid 'shot' (40ml / 1.35oz.) form, today announced it has completed a Series A financing round.  New investor Sofinnova Ventures led the round.   (Logo:  http://photos.prnewswire.com/prnh/20130521/SF182...

Safeguard Scientifics Annual Meeting of Shareholders to Be Held on Thursday, May 23 at 8:00 A.M. EDT

Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage healthcare and technology companies, today announced that its annual meeting of shareholders will be held on Thursday, May 23, 2013 at 8:00 a.m. EDT at the Courtyard P

Medtronic's CEO Discusses F4Q 2013 Results - Earnings Call Transcript

Medtronic (MDT) F4Q 2013 Results Earnings Call May 21, 2013 8:00 a.m. ET Executives Jeff Warren - Vice President, Investor Relations Omar Ishrak - Chairman and Chief Executive Officer Gary Ellis - Chief Financial Officer Mike Coyle - President, Cardiac and Vascular Group Chris O’Connell - President, Restorative Therapies Group Analysts Matthew Dodd - Citigroup Mike Weinstein - JPMorgan...

CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors

Aldoxorubicin shows prolonged clinical activity in two clinical trial patients with small cell lung cancer who have failed other therapies Data show that aldoxorubicin demonstrates a significant 250-fold lower distribution to healthy tissue compared with doxorubicin CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and deve...

New Index of 5,000 U.S. Physicians Reveals Downward Trend In Profitability For The Year Ahead, With Healthcare Reform Fueling Top Operational Challenges

48% Of Physicians Do Not Foresee Ability to Accept New Patients From Accountable Care Act, Impacting Access To Care, According to Physician Profitability Index CareCloud, a leading provider of cloud-based practice management,

ALung to Pursue SFDA Approval of Hemolung RAS in China

Agreement Signed with Curative Medical to Initiate Clinical Trial ALung Technologies, Inc., a leading developer of innovative respiratory assist devices, today announced that it has signed an agreement with Curative Medical, Inc. to pursue China’s State Food and Drug Administration (“SFDA”) approval for the Hemolung Respiratory Assist System (RAS...

Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million

       Xellia is a leading developer and manufacturer of anti-infective therapies for multi-drug resistant infections. With this acquisition Novo expands its long-term investment portfolio with a further major life-science company in Denmark and will contribute to the future growth of Xellia. Oslo, Norway and Copenhagen, Denmark, May 21 2013 – Xellia Pharmaceuticals...